The
global tuberculosis testing market continues to grow as governments
and institutions across the globe continue to make efforts to
eradicate this deadly communicable disease. Statistics gathered by
the WHO state that 9 million people acquired tuberculosis (TB) in
2013 and 1.5 met a fatal end, out of which 360,000 were HIV positive.
These figures are declining with each passing year thanks to the
increasingly effective diagnosis and treatment options offered to
patients. It is estimated that such initiatives were able to save the
lives of 37 million tuberculosis patients between 2000 and 2013.
Browse
Full Global Tuberculosis Testing Market Report With Complete TOC @
http://www.transparencymarketresearch.com/tuberculosis-testing-market.html
Tuberculosis
can be broken down into two types, namely active disease, which can
transform to multi-drug resistant TB or MDR-TB, and latent disease.
Tuberculosis also has a rare form called miliary TB, which occurs
when TB infection finds its way to the bloodstream. The priority
steps to counter MDR-TB are supreme quality of treatment for
drug-susceptible TB to avert MDR-TB, expanding the reach of testing
and detection of MDR-TB cases to remote regions, simplifying the
access to good healthcare, infection control, and strengthening the
political commitment, especially in BRIC nations, which constitute
50% of global TB cases.
Dedicated
Efforts of Non-profit Organizations Drive Global Tuberculosis Testing
Market
The
efforts taken by governments, social activists, and several
healthcare institutions have translated into positive results. A
ripple effect of these efforts can also be seen in the growth of the
global tuberculosis testing market. The global tuberculosis testing
market was worth US$1,936.1 million in 2013. By 2020 this market is
expected to reach a valuation of US$2,619.4 million, growing at a
promising CAGR of 4.3% from 2014 to 2020.
The
factors driving this gigantic growth are the rising number of
tuberculosis cases, increasing acceptance of innovative methods for
treating tuberculosis, and enhanced molecular and rapid culture
diagnostic tests. The serious involvement and dedicated efforts of
non-profit healthcare organizations are further boosting the global
tuberculosis testing market. Growing tuberculosis cases have also
resulted in increased research and development budgets, encouraging
manufacturers to launch better testing technologies.
Serological
Tests and IGRA Sub-segments to Grow the Fastest
The
global tuberculosis testing market is classified on the basis of type
and geography. The segments by product type are culture-based tests,
smear microscopy, nucleic acid testing, radiography (chest x-ray),
Mantoux test (tuberculin skin test), drug susceptibility test (DST),
and other tests such as serological tests, ADA, and IGRA.
Geographically, the global tuberculosis testing market is fragmented
into North America, Asia Pacific, Europe, and Rest of the World.
Browse
Full Press Release report
http://www.transparencymarketresearch.com/pressrelease/tuberculosis-testing-market.htm
Out
of these segments, culture-based tests hold a lion’s share in the
global tuberculosis testing market. These tests are inclusive of both
solid and liquid culture tests. Analysts predict that other segments
such as serological tests and IGRA will grow rapidly in the coming
five years as well. All of these tuberculosis testing methods
generate quick results, offer improved accuracy, and require the
patient to just one visit.
India
and China to Make Steady Contribution to Growth of Global
Tuberculosis Market
Geographically,
Asia Pacific led the global tuberculosis testing market in 2013,
closely followed by North America. The prime factor driving the
unprecedented growth rate in Asia Pacific is a huge patient pool,
which continues to grow at a rapid rate, especially in countries such
as China and India. Though North America has a smaller patient pool,
the tuberculosis testing market is expected to grow in this region
due to increasing awareness, better healthcare infrastructure, and
growing acceptance and adoption of expensive TB tests due to
improving purchasing power of patients.
Some
of the key players in the global tuberculosis testing market are
Akonni Biosystems Inc., Abbott Laboratories, Becton, Alere Inc.,
Dickinson and Company, Cepheid, Epistem plc, bioMérieux SA, F.
Hoffmann-La Roche Ltd., Hologic, QIAGEN, Hain Lifescience GmbH,
Sanofi, and Thermo Fisher Scientific Inc.
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2267
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants, use
proprietary data sources and various tools and techniques to gather,
and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket Ghumare
90
State Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
